Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 25, Issue 8, 2010, Pages 780-788

  Berlow, Yosef A ^a,b   Wells, William M ^b,c,d   Ellison, James M ^a,b   Sung, Young Hoon ^a,b   Renshaw, Perry F ^a,b   Harper, David G ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Behavioral and psychological symptoms of dementia; Magnetic resonance imaging; Neuropsychiatric inventory; White matter hyperintensities

Indexed keywords

AGED; ALZHEIMER DISEASE; ANXIETY; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHIATRIC INVENTORY; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; RELIABILITY; RETROSPECTIVE STUDY; SLEEP DISORDER; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; BRIEF PSYCHIATRIC RATING SCALE; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES;

EID: 77955373439     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2418     Document Type: Article

References (66)

1. Aharon-Peretz J, Masiah A, Pillar T, et al. 1991. Sleep-wake cycles in multi-infarct dementia and dementia of the Alzheimer type. Neurology 41: 1616-1619 (lost in the final stages of Alzheimer's disease).
2. Assal F, Cummings JL. 2002. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 15: 445-450.
3. Association AP. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington D.C.; American Psychiatric Association.
4. Ballard C, Neill D, O'Brien J, et al. 2000. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59: 97-106.
5. Barber R, Scheltens P, Gholkar A, et al. 1999. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 67: 66-72.
6. Bassetti CL, Milanova M, Gugger M. 2006. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37: 967-972.
7. Beeri MS, Werner P, Davidson M, Noy S. 2002. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry 17: 403-408.
8. Berger G, Bernhardt T, Weimer E, et al. 2005. Longitudinal study on the relationship between symptomatology of dementia and levels of subjective burden and depression among family caregivers in memory clinic patients. J Geriatr Psychiatry Neurol 18: 119-128.
9. Bigler ED, Lowry CM, Kerr B, et al. 2003. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. Neuropsychology 17: 339-352.
10. Bigler ED, Neeley ES, Miller MJ, et al. 2004. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia. J Int Neuropsychol Soc 10: 442-452.
11. Chemerinski E, Levine SR. 2006. Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med 73: 1006-1014.
12. Clark LM, McDonald WM, Welsh-Bohmer KA, et al. 1998. Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. Biol Psychiatry 44: 592-599.
13. Crum RM, Anthony JC, Bassett SS, Folstein MF. 1993. Population-based norms for the Mini-Mental State Examination by age and educational level. Jama 269: 2386-2391.
14. Cummings JL. 1997. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 48: S10-16.
15. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. 2005. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 36: 50-55.
16. Del Ser T, Hachinski V, Merskey H, Munoz DG. 2005. Alzheimer's disease with and without cerebral infarcts. J Neurol Sci 231: 3-11.
17. Duvernoy HM. 1999. The Human Brain: Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply. New York; Springer.
18. Erkinjuntti T, Partinen M, Sulkava R, et al. 1987. Sleep apnea in multiinfarct dementia and Alzheimer's disease. Sleep 10: 419-425.
19. Firbank MJ, O'Brien JT, Pakrasi S, et al. 2005. White matter hyperintensities and depression-preliminary results from the LADIS study. Int J Geriatr Psychiatry 20: 674-679.
20. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
21. Fuh JL, Wang SJ, Cummings JL. 2005. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry 76: 1337-1341.
22. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. 1996. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 27: 252-259.
23. Gunning-Dixon FM, Raz N. 2000. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14: 224-232.
24. Hart DJ, Craig D, Compton SA, et al. 2003. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry 18: 1037-1042.
25. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60: 1119-1122.
26. Hirono N, Mori E, Ishii K, et al. 1998. Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology 50: 380-383. (Pubitemid 28119774)
27. Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E. 2000. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke 31: 1263-1268.
28. Holthoff VA, Beuthien-Baumann B, Kalbe E, et al. 2005. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry 57: 412-421.
29. Horinek D, Petrovicky P, Hort J, et al. 2006. Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis. Acta Neurol Scand 113: 40-45.
30. Jenkinson M, Smith S. 2001. A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
31. Kim JM, Lyons D, Shin IS, Yoon JS. 2003. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable? Hum Psychopharmacol 18: 215-220.
32. Lee DY, Choo IH, Kim KW, et al. 2006. White matter changes associated with psychotic symptoms in Alzheimer's disease patients. J Neuropsychiatry Clin Neurosci 18: 191-198.
33. McArdle N, Hillman D, Beilin L, Watts G. 2007. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175: 190-195.
34. McCurry SM, Gibbons LE, Logsdon RG, Teri L. 2004. Anxiety and night-time behavioral disturbances. Awakenings in patients with Alzheimer's disease. J Gerontol Nurs 30: 12-20.
35. McGraw KO, Wong SO. 1996. Forming inferences about some intraclass correlation coefficients. Psychol Meth 1: 30-46.
36. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-944.
37. Meguro K, Ueda M, Kobayashi I, et al. 1995. Sleep disturbance in elderly patients with cognitive impairment, decreased daily activity and periventricular white matter lesions. Sleep 18: 109-114.
38. Mishima K, Okawa M, Satoh K, et al. 1997. Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multiinfarct dementia. Neurobiol Aging 18: 105-109.
39. Mok WY, Chu LW, Chung CP, Chan NY, Hui SL. 2004. The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease. Int J Geriatr Psychiatry 19: 1040-1046.
40. Moran M, Lynch CA, Walsh C, et al. 2005. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 6: 347-352.
41. Morrison V, Pollard B, Johnston M, MacWalter R. 2005. Anxiety and depression 3 years following stroke: demographic, clinical, and psychological predictors. J Psychosom Res 59: 209-213.
42. Murman DL, Chen Q, Powell MC, et al. 2002. The incremental direct costs associated with behavioral symptoms in AD. Neurology 59: 1721-1729.
43. Murphy DG, DeCarli CD, Daly E, et al. 1993. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry 34: 612-621.
44. O'Brien JT, Wiseman R, Burton EJ, et al. 2002. Cognitive associations of subcortical white matter lesions in older people. Ann N Y Acad Sci 977: 436-444.
45. Petersen RC, Jack CR Jr, Xu YC, et al. 2000. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 54: 581-587.
46. Porter VR, Buxton WG, Fairbanks LA, et al. 2003. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci 15: 180-186.
47. Rapoport MJ, van Reekum R, Freedman M, et al. 2001. Relationship of psychosis to aggression, apathy and function in dementia. Int J Geriatr Psychiatry 16: 123-130.
48. Rorden C, Brett M. 2000. Stereotaxic display of brain lesions. Behav Neurol 12: 191-200.
49. Rosen HJ, Allison SC, Schauer GF, et al. 2005. Neuroanatomical correlates of behavioural disorders in dementia. Brain 128: 2612-2625.
50. Scarmeas N, Brandt J, Albert M, et al. 2005. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 62: 1601-1608.
51. Scheltens P, Barkhof F, Leys D, et al. 1993. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7-12.
52. Scheltens P, Barkhof F, Leys D, et al. 1995. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45: 883-888.
53. Shimabukuro J, Awata S, Matsuoka H. 2005. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients. Psychiatry Clin Neurosci 59: 274-279.
54. Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. 2005. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry 13: 469-474.
55. Smith SM. 2002. Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155.
56. Smith SM, Zhang Y, Jenkinson M, et al. 2002. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17: 479-489.
57. Spalletta G, Baldinetti F, Buccione I, et al. 2004. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease. J Neurol 251: 688-695.
58. Starkstein SE, Sabe L, Vazquez S, et al. 1997. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry 63: 66-73.
59. Steele C, Rovner B, Chase GA, Folstein M. 1990. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 147: 1049-1051.
60. Stout JC, Jernigan TL, Archibald SL, Salmon DP. 1996. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 53: 742-749.
61. Sultzer DL, Brown CV, Mandelkern MA, et al. 2003. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry 160: 341-349.
62. Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. 1993. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 150: 1806-1812.
63. Tractenberg RE, Weiner MF, Cummings JL, Patterson MB, Thal LJ. 2005. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. J Neuropsychiatry Clin Neurosci 17: 51-60.
64. van Straaten EC, Fazekas F, Rostrup E, et al. 2006. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37: 836-840.
65. Watson C, Andermann F, Gloor P, et al. 1992. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 42: 1743-1750.
66. Zhang Y, Brady M, Smith S. 2001. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.